Altamira Therapeutics Ltd. Expected Cash Outflow On Redemption Or Repurchase Of Puttable Financial Instruments
Altamira Therapeutics Ltd. (CYTOF) had Expected Cash Outflow On Redemption Or Repurchase Of Puttable Financial Instruments of $16.77 thousand as of 2023-05-01, per its 6-K filed 2024-09-24.
Discontinued › Notes
ifrs-full:ExpectedCashOutflowOnRedemptionOrRepurchaseOfPuttableFinancialInstruments · last filed 2024-09-24
- 2023-05-01: Expected Cash Outflow On Redemption Or Repurchase Of Puttable Financial Instruments $16.77K.
| Period end | Expected Cash Outflow On Redemption Or Repurchase Of Puttable Financial Instruments |
|---|---|
| 2023-05-01 | $16.77K 6-K · filed 2024-09-24 |